State Street’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,384,677
Closed -$162M 4993
2022
Q3
$162M Sell
2,384,677
-2,038,867
-46% -$139M 0.01% 818
2022
Q2
$141M Buy
4,423,544
+967,532
+28% +$30.9M 0.01% 941
2022
Q1
$120M Buy
3,456,012
+284,877
+9% +$9.87M 0.01% 1167
2021
Q4
$92.8M Buy
3,171,135
+63,408
+2% +$1.86M ﹤0.01% 1356
2021
Q3
$79.2M Buy
3,107,727
+806,900
+35% +$20.6M ﹤0.01% 1454
2021
Q2
$80.6M Buy
2,300,827
+449,419
+24% +$15.7M ﹤0.01% 1477
2021
Q1
$75.4M Sell
1,851,408
-424,301
-19% -$17.3M ﹤0.01% 1450
2020
Q4
$98.6M Buy
2,275,709
+635,550
+39% +$27.5M 0.01% 1157
2020
Q3
$90.4M Buy
1,640,159
+70,954
+5% +$3.91M 0.01% 1035
2020
Q2
$99.1M Sell
1,569,205
-618,178
-28% -$39M 0.01% 969
2020
Q1
$112M Buy
2,187,383
+29,555
+1% +$1.51M 0.01% 800
2019
Q4
$172M Sell
2,157,828
-213,639
-9% -$17M 0.01% 755
2019
Q3
$115M Buy
2,371,467
+181,054
+8% +$8.78M 0.01% 919
2019
Q2
$115M Sell
2,190,413
-207,602
-9% -$10.9M 0.01% 939
2019
Q1
$127M Buy
2,398,015
+209,919
+10% +$11.1M 0.01% 874
2018
Q4
$89.8M Sell
2,188,096
-405,068
-16% -$16.6M 0.01% 963
2018
Q3
$98.5M Buy
2,593,164
+173,001
+7% +$6.57M 0.01% 1087
2018
Q2
$109M Buy
2,420,163
+373,768
+18% +$16.9M 0.01% 977
2018
Q1
$98.8M Buy
2,046,395
+224,586
+12% +$10.8M 0.01% 1014
2017
Q4
$71.7M Sell
1,821,809
-181,611
-9% -$7.15M 0.01% 1212
2017
Q3
$62.2M Sell
2,003,420
-134,903
-6% -$4.19M 0.01% 1245
2017
Q2
$58.5M Buy
2,138,323
+1,465,595
+218% +$40.1M 0.01% 1267
2017
Q1
$24.8M Buy
672,728
+382,744
+132% +$14.1M ﹤0.01% 1780
2016
Q4
$4.17M Buy
289,984
+4,024
+1% +$57.9K ﹤0.01% 2783
2016
Q3
$6.59M Buy
285,960
+106,934
+60% +$2.47M ﹤0.01% 2412
2016
Q2
$2.97M Buy
179,026
+85,154
+91% +$1.41M ﹤0.01% 2878
2016
Q1
$1.49M Buy
93,872
+5,764
+7% +$91.6K ﹤0.01% 3090
2015
Q4
$2.85M Buy
88,108
+12,875
+17% +$416K ﹤0.01% 2847
2015
Q3
$3.17M Buy
+75,233
New +$3.17M ﹤0.01% 2771